INS and Cognitive impairment: Insulin/IGF-I signaling deficient mice report a delayed onset of fatal malignancies, increased insulin sensitivity, and a reduction in age-dependent cognitive impairment, including protection from Alzheimer’s disease (AD)-like associated pathologies [29].